These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11084244)

  • 1. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits.
    Shin SC; Bum JP; Choi JS
    Int J Pharm; 2000 Nov; 209(1-2):37-43. PubMed ID: 11084244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide.
    Nicolazzo JA; Reed BL; Finnin BC
    J Control Release; 2005 Jul; 105(3):240-8. PubMed ID: 15921776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced permeation of triamcinolone acetonide through the buccal mucosa.
    Shin SC; Kim JY
    Eur J Pharm Biopharm; 2000 Sep; 50(2):217-20. PubMed ID: 10962230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of the buccal mucosa and wounded skin in rats with a triamcinolone acetonide-loaded hydrogel prepared using an electron beam.
    Choi SG; Baek EJ; Davaa E; Nho YC; Lim YM; Park JS; Gwon HJ; Huh KM; Park JS
    Int J Pharm; 2013 Apr; 447(1-2):102-8. PubMed ID: 23467084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions.
    Ali J; Khar RK; Ahuja A
    Pharmazie; 1998 May; 53(5):329-34. PubMed ID: 9631501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study.
    Dhiman MK; Dhiman A; Sawant KK
    AAPS PharmSciTech; 2009; 10(1):258-65. PubMed ID: 19280347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microemulsion containing triamcinolone acetonide for buccal administration.
    Padula C; Telò I; Di Ianni A; Pescina S; Nicoli S; Santi P
    Eur J Pharm Sci; 2018 Mar; 115():233-239. PubMed ID: 29414307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of triprolidine from the transdermal TPX matrix system in rabbits.
    Shin SC; Choi JS
    Int J Pharm; 2002 Mar; 234(1-2):67-73. PubMed ID: 11839438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive and physicochemical characterization of Carbopol-Poloxamer gels containing triamcinolone acetonide.
    Shin SC; Kim JY; Oh IJ
    Drug Dev Ind Pharm; 2000 Mar; 26(3):307-12. PubMed ID: 10738647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration.
    Derendorf H; Hochhaus G; Rohatagi S; Möllmann H; Barth J; Sourgens H; Erdmann M
    J Clin Pharmacol; 1995 Mar; 35(3):302-5. PubMed ID: 7608322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of triamcinolone acetonide and hydrocortisone in human plasma by high-performance liquid chromatography.
    Döppenschmitt SA; Scheidel B; Harrison F; Surmann JP
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):79-88. PubMed ID: 8832428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic study to evaluate the absolute bioavailability of triamcinolone acetonide following inhalation administration.
    Argenti D; Shah B; Heald D
    J Clin Pharmacol; 1999 Jul; 39(7):695-702. PubMed ID: 10392324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of dissolved cellulose in development of buccal discs for oromucosal drug delivery.
    Yildir E; Sjöholm E; Preis M; Trivedi P; Trygg J; Fardim P; Sandler N
    Pharm Dev Technol; 2018 Jun; 23(5):520-529. PubMed ID: 29067849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2003 Nov; 56(3):439-43. PubMed ID: 14602188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of hydrocolloid patch composition on the bioavailability of triamcinolone acetonide in humans.
    Martin GP; Ladenheim D; Marriott C; Hollingsbee DA; Brown MB
    Drug Dev Ind Pharm; 2000 Jan; 26(1):35-43. PubMed ID: 10677808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax-film composite disks.
    Jay S; Fountain W; Cui Z; Mumper RJ
    J Pharm Sci; 2002 Sep; 91(9):2016-25. PubMed ID: 12210048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro permeation studies of triamcinolone acetonide mouthwashes.
    Ungphaiboon S; Maitani Y
    Int J Pharm; 2001 Jun; 220(1-2):111-7. PubMed ID: 11376973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.
    Chin HS; Park TS; Moon YS; Oh JH
    Retina; 2005; 25(5):556-60. PubMed ID: 16077349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian changes in the pharmacokinetics of triamcinolone acetonide in rabbits.
    Choi JS; Shin SC; Burm JP
    Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):233-8. PubMed ID: 11484877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.